Nkarta (NKTX) Total Non-Current Liabilities (2019 - 2026)

Nkarta's quarterly Total Non-Current Liabilities came in at $86.1 million in Q1 2026, down 6.1% year-on-year from $91.7 million in Q1 2025, and down 6.18% quarter-over-quarter from $91.8 million in Q4 2025.

Nkarta has reported Total Non-Current Liabilities for 7 years, with the latest figure at $86.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 6.1% year-over-year to $86.1 million; the trailing twelve-month figure through Mar 2026 stood at $86.1 million (down 6.1% YoY), and the FY2025 full-year result was $91.8 million, down 1.44% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $86.1 million, down from $91.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $104.5 million in Q3 2022, with the low at $77.6 million in Q1 2022.
  • Average Total Non-Current Liabilities over 4 years is $89.7 million, with a median of $90.6 million recorded in 2025.
  • Year-over-year, Total Non-Current Liabilities surged 366.69% in 2022 and retreated 6.1% in 2026.
  • Tracing NKTX's Total Non-Current Liabilities over 4 years: stood at $104.5 million in 2022, then declined by 10.9% to $93.1 million in 2024, then decreased by 1.44% to $91.8 million in 2025, then fell by 6.18% to $86.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $86.1 million (Q1 2026), $91.8 million (Q4 2025), and $89.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Nkarta 232.80 Mn 232.80 Mn - 86.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 86.13 Mn
Dec 31, 2025 91.80 Mn
Sep 30, 2025 89.25 Mn
Jun 30, 2025 90.56 Mn
Mar 31, 2025 91.72 Mn
Dec 31, 2024 93.14 Mn
Sep 30, 2022 104.53 Mn
Jun 30, 2022 82.59 Mn
Mar 31, 2022 77.58 Mn
Dec 31, 2021 22.92 Mn
Sep 30, 2021 22.40 Mn
Jun 30, 2021 20.66 Mn
Mar 31, 2021 19.63 Mn
Dec 31, 2020 16.35 Mn
Sep 30, 2020 17.22 Mn
Jun 30, 2020 67.57 Mn
Dec 31, 2019 13.95 Mn